학술논문

Low-dose interleukin 2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial
Document Type
Article
Source
In: BMJ Open. (BMJ Open, 7 October 2022, 12(10))
Subject
Language
English
ISSN
20446055